{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:07:26Z","timestamp":1779106046029,"version":"3.51.4"},"reference-count":18,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/ol.2012.1075","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T13:10:34Z","timestamp":1355404234000},"page":"593-597","source":"Crossref","is-referenced-by-count":29,"title":["Staging recurrent ovarian cancer with 18FDG PET\/CT"],"prefix":"10.3892","volume":"5","author":[{"given":"SANJA","family":"DRAGOSAVAC","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOPHIE","family":"DERCHAIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NELSON M.G.","family":"CASERTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUSTAVO","family":"DE SOUZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"key":"key20180108092928_b1-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0140-6736(05)17716-2","article-title":"Epidemiology of ovarian cancer: a status report","volume":"365","author":"Bertone-Johnson","year":"2005","journal-title":"Lancet"},{"key":"key20180108092928_b2-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180108092928_b3-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108092928_b4-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"key":"key20180108092928_b5-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(07)70273-5","article-title":"Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations","volume":"8","author":"Goonewardene","year":"2007","journal-title":"Lancet Oncol"},{"issue":"Suppl 4","key":"key20180108092928_b6-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"L87","DOI":"10.1007\/s00330-003-1964-y","article-title":"Ovarian cancer: the clinical role of US, CT, and MRI","volume":"13","author":"Togashi","year":"2003","journal-title":"Eur Radiol"},{"key":"key20180108092928_b7-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1148\/radiol.2353040447","article-title":"Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year","volume":"235","author":"Low","year":"2005","journal-title":"Radiology"},{"key":"key20180108092928_b8-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","article-title":"The impact of PET\/CT in the management of recurrent ovarian cancer","volume":"103","author":"Simcock","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180108092928_b9-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MNM.0b013e32831089cb","article-title":"18F-FDG PET\/CT evaluation of patients with ovarian carcinoma","volume":"29","author":"Iagaru","year":"2008","journal-title":"Nucl Med Commun"},{"key":"key20180108092928_b10-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00259-010-1416-2","article-title":"Clinical value of FDG PET\/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET\/CT on patient management?","volume":"37","author":"Bilici","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key20180108092928_b11-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2007.07.082","article-title":"Impact of FDG PET\/CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence","volume":"108","author":"Soussan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180108092928_b12-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","article-title":"(18)F-FDG PET\/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients","volume":"31","author":"Nanni","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"key20180108092928_b13-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00404-010-1404-6","article-title":"Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer","volume":"283","author":"Pan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"key20180108092928_b14-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ygyno.2008.08.027","article-title":"The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project","volume":"112","author":"Fulham","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20180108092928_b15-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","article-title":"Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: A meta-analysis","volume":"81","author":"Yuan","year":"2012","journal-title":"Eur J Radiol"},{"key":"key20180108092928_b16-ol-05-02-0593","first-page":"283","article-title":"Application of intravenous contrast in PET\/CT: does it really introduce significant attenuation correction error?","volume":"46","author":"Yau","year":"2005","journal-title":"J Nucl Med"},{"key":"key20180108092928_b17-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2967\/jnumed.106.036350","article-title":"18F-FDG PET\/CT delayed images after diuretic for restaging invasive bladder cancer","volume":"48","author":"Anjos","year":"2007","journal-title":"J Nucl Med"},{"key":"key20180108092928_b18-ol-05-02-0593","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM199004123221512","article-title":"Second thoughts about second-look laparotomy in advanced ovarian cancer","volume":"322","author":"Friedman","year":"1990","journal-title":"N Engl J Med"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.1075\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T10:51:25Z","timestamp":1515408685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.1075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,13]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,13]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/ol.2012.1075"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.1075","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,13]]}}}